bioMérieux’s ambition is to become a key player in the in vitro diagnostics field of infectious diseases and other pathologies, such as cardiovascular diseases or cancers. We have implemented the following strategy:

• focusing development on applications with a high potential
• launching new products to better satisfy the needs of patients and the imperatives of public health in general
• reinforcing our worldwide network to seize growth opportunities
• continuing with our sustained effort in research and development
• investing in new technologies via strategic alliances and targeted purchases that guarantee growth and technological independence
• pursuing a balanced financial strategy to seize on growth opportunities